NexGenix Pharmaceuticals Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A

NexGenix Pharmaceuticals General Information

Description

Developer of therapies designed for oncology and nervous system diseases. The company's services include developing a non-surgical intralesional treatment for dermal neurofibromas, enabling healthcare practitioners to provide targeted therapies for cancer and diseases of the nervous system such as glioblastoma, neurodegenerative diseases, neurofibromatosis, and autism-spectrum disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 30 East 85th Street
  • Suite 3B
  • New York, NY 10028
  • United States
+1 (212)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 30 East 85th Street
  • Suite 3B
  • New York, NY 10028
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NexGenix Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-May-2013 Completed Generating Revenue
6. Grant Completed Generating Revenue
5. Early Stage VC Completed Generating Revenue
4. Grant 23-Oct-2009 Completed Generating Revenue
3. Early Stage VC (Series B) 13-Jul-2007 Completed Generating Revenue
2. Early Stage VC (Series A) Completed Startup
1. Corporate Completed Startup
To view NexGenix Pharmaceuticals’s complete valuation and funding history, request access »

NexGenix Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NexGenix Pharmaceuticals Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Children's Tumor Foundation Corporation Minority
National Institutes of Neurological Disorders and Stroke Government
United States Department of War Government
To view NexGenix Pharmaceuticals’s complete investors history, request access »

NexGenix Pharmaceuticals FAQs

  • Where is NexGenix Pharmaceuticals headquartered?

    NexGenix Pharmaceuticals is headquartered in New York, NY.

  • What is the size of NexGenix Pharmaceuticals?

    NexGenix Pharmaceuticals has 4 total employees.

  • What industry is NexGenix Pharmaceuticals in?

    NexGenix Pharmaceuticals’s primary industry is Drug Discovery.

  • Is NexGenix Pharmaceuticals a private or public company?

    NexGenix Pharmaceuticals is a Private company.

  • What is NexGenix Pharmaceuticals’s current revenue?

    The current revenue for NexGenix Pharmaceuticals is .

  • How much funding has NexGenix Pharmaceuticals raised over time?

    NexGenix Pharmaceuticals has raised $13.9M.

  • Who are NexGenix Pharmaceuticals’s investors?

    Children's Tumor Foundation, National Institutes of Neurological Disorders and Stroke, and United States Department of War have invested in NexGenix Pharmaceuticals.

  • When was NexGenix Pharmaceuticals acquired?

    NexGenix Pharmaceuticals was acquired on 01-May-2013.

  • Who acquired NexGenix Pharmaceuticals?

    NexGenix Pharmaceuticals was acquired by OncoSynergy.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process